Mark Hopman serves as Executive at Beta Bionics, Inc., where they oversee executive responsibilities. Since joining the company, Mark Hopman has executed 8 insider transactions totaling $655.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 5, 2025 involved selling 11,411 shares valued at $234.6K.
Mark Hopman currently holds 31,215 shares of Beta Bionics, Inc. (BBNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Hopman has been a net seller of BBNX stock. They have purchased $0 and sold $655.1K worth of shares.
Mark Hopman's most recent insider trade was on Sep 5, 2025, when they sold 11,411 shares at $20.56 per share.
Get notified when new Form 4 filings are submitted
| $5.10 |
| Discretionary |
| Sep 4, 2025 | BBNX | $136.2K | Sale | 6,818 | $19.97 | Discretionary |
| Sep 4, 2025 | BBNX | $3.3K | Option Exercise | 656 | $5.10 | Discretionary |
| Sep 4, 2025 | BBNX | $20.9K | Option Exercise | 4,093 | $5.10 | Discretionary |
| Sep 2, 2025 | BBNX | $16.0K | Sale | 848 | $18.86 | Discretionary |
| Aug 19, 2025 | BBNX | $82.4K | Option Exercise | 16,158 | $5.10 | Discretionary |
| Aug 19, 2025 | BBNX | $268.4K | Sale | 16,158 | $16.61 | Discretionary |